Skip to content

Clinical trials

Intellectual Disability trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intellectual Disability Phase: Not applicable Clear all

195 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20072
20091
20101
20125
20134
20145
20153
201613
20175
201811
201911
202012
202116
202216
202322
202414
202528
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed112
Recruiting28
Unknown status23
Not yet recruiting10
Active, not recruiting9
Enrolling by invitation7
Terminated3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
The University of Hong Kong4
University of Kansas Medical Center4
Assistance Publique - Hôpitaux de Paris3
Burdur Mehmet Akif Ersoy University3
Hong Kong Baptist University3
Hôpital le Vinatier3
Karolinska Institutet3
Ostfold University College3
Selcuk University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intellectual Disability195
Autism Spectrum Disorder33
Developmental Disabilities29
Autistic Disorder15
Down Syndrome13
Lymphoma, Follicular12
Learning Disabilities10
Neurodevelopmental Disorders9
Obesity8
Attention Deficit Disorder with Hyperactivity5

Trials

Showing 76 to 100 of 195. Each trial links to its page on Pharma Observatory.

95 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.